A New Vaccine to Battle Covid-19

doi:10.1056/NEJMe2035557

Editorial

. 2021 Feb 4;384(5):470-471.

doi: 10.1056/NEJMe2035557. Epub 2020 Dec 30.

A New Vaccine to Battle Covid-19

Barton F Haynes¹

Affiliations

PMID: 33378607
PMCID: PMC7787216
DOI: 10.1056/NEJMe2035557

Editorial

A New Vaccine to Battle Covid-19

Barton F Haynes. N Engl J Med. 2021.

. 2021 Feb 4;384(5):470-471.

doi: 10.1056/NEJMe2035557. Epub 2020 Dec 30.

Author

Barton F Haynes¹

Affiliation

¹ From the Departments of Medicine and Immunology, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC.

PMID: 33378607
PMCID: PMC7787216
DOI: 10.1056/NEJMe2035557

No abstract available

PubMed Disclaimer

Comment on

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.

Cited by

mRNA vaccine development and applications: A special focus on tumors (Review).
Chen B, Yang Y, Wang X, Yang W, Lu Y, Wang D, Zhuo E, Tang Y, Su J, Tang G, Shao S, Gu K. Chen B, et al. Int J Oncol. 2024 Aug;65(2):81. doi: 10.3892/ijo.2024.5669. Epub 2024 Jul 12. Int J Oncol. 2024. PMID: 38994758 Free PMC article. Review.
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development.
Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Mehta M, et al. ACS Mater Au. 2023 Aug 21;3(6):600-619. doi: 10.1021/acsmaterialsau.3c00032. eCollection 2023 Nov 8. ACS Mater Au. 2023. PMID: 38089666 Free PMC article. Review.
COVID-19 emergency: the influence of implicit attitudes, information sources, and individual characteristics on psychological distress, intentions to get vaccinated, and compliance with restrictive rules.
Colledani D, Anselmi P, Robusto E. Colledani D, et al. Health Psychol Rep. 2021 Dec 6;10(1):1-12. doi: 10.5114/hpr.2021.111292. eCollection 2022. Health Psychol Rep. 2021. PMID: 38084370 Free PMC article.
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response.
Mohan A, Iyer VA, Kumar D, Batra L, Dahiya P. Mohan A, et al. Life (Basel). 2023 Oct 26;13(11):2121. doi: 10.3390/life13112121. Life (Basel). 2023. PMID: 38004261 Free PMC article. Review.
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection.
Ronk AJ, Lloyd NM, Zhang M, Atyeo C, Perrett HR, Mire CE, Hastie KM, Sanders RW, Brouwer PJM, Saphire EO, Ward AB, Ksiazek TG, Alvarez Moreno JC, Thaker HM, Alter G, Himansu S, Carfi A, Bukreyev A. Ronk AJ, et al. Nat Commun. 2023 Sep 12;14(1):5603. doi: 10.1038/s41467-023-41376-6. Nat Commun. 2023. PMID: 37699929 Free PMC article.

See all "Cited by" articles

References

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-2615. - PMC - PubMed
1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. DOI: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
1. Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383:2427-2438. - PMC - PubMed
1. Graham BS. Rapid COVID-19 vaccine development. Science 2020;368:945-946. - PubMed
1. Haynes BF, Corey L, Fernandes P, et al. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12(568):eabe0948-eabe0948. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-2615. - PMC - PubMed

[2] Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-2615. - PMC - PubMed

[3] Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. DOI: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed

[4] Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. DOI: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed

[5] Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383:2427-2438. - PMC - PubMed

[6] Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383:2427-2438. - PMC - PubMed

[7] Graham BS. Rapid COVID-19 vaccine development. Science 2020;368:945-946. - PubMed

[8] Graham BS. Rapid COVID-19 vaccine development. Science 2020;368:945-946. - PubMed

[9] Haynes BF, Corey L, Fernandes P, et al. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12(568):eabe0948-eabe0948. - PubMed

[10] Haynes BF, Corey L, Fernandes P, et al. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12(568):eabe0948-eabe0948. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A New Vaccine to Battle Covid-19

Affiliation

A New Vaccine to Battle Covid-19

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical